BioLife Solutions

Forecast & Rating9 analysts currently cover BioLife Solutions, with about 22.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $31.13, about 4.7% downside from the current price of $32.67. Price targets are fairly clustered, pointing to relatively aligned views. Historically, about 46.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on BioLife Solutions's outlook. Data as of Jul 27, 2026; for reference only and not investment advice.